News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

A Jilted Shire Pharmaceuticals (SHPG) Exec, Age Discrimination and a Federal Probe?


5/31/2013 7:25:01 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Was the head of regenerative medicine at Shire Pharmaceuticals fooled into accepting a promotion? Jeff Jonas claims in a lawsuit that the biotech failed to disclose the unit faced declining sales, a probe by the feds into illegal marketing and that a new Shire ceo was about to be named right after he began his new job. Had he known all this, Jones maintains he would have instead taken another job offer. The mess began last fall, when Jonas approached former Shire ceo Angus Russell about his desire for a position with added responsibilities since he was being offered such opportunity elsewhere. And so, last November he was named president of regenerative medicine and moved from Philadelphia to San Diego, where the unit was based, according to the lawsuit.

Help employers find you! Check out all the jobs and post your resume.

Read at PharmaLive


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES